Using cell surface markers Al-Hajj and colleagues found that CD44+CD24−/low Lin− cells from breast cancer patients were significantly enriched for tumor forming ability in NOD/SCID mice compared with CD44+CD24+ Lin− cells. This evidence concerns the gene CD44 and breast cancer.